Summary
10.52 -0.11(-1.03%)07/03/2024
Ultralife Corp (ULBI)
Ultralife Corp (ULBI)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-1.13 | 2.14 | -6.98 | 9.24 | 61.35 | 113.39 | 27.98 | -20.60 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 10.52 | |
Open | 10.75 | |
High | 10.75 | |
Low | 10.46 | |
Volume | 34,305 | |
Change | -0.12 | |
Change % | -1.13 | |
Avg Volume (20 Days) | 95,046 | |
Volume/Avg Volume (20 Days) Ratio | 0.36 | |
52 Week Range | 4.62 - 13.39 | |
Price vs 52 Week High | -21.43% | |
Price vs 52 Week Low | 127.71% | |
Range | -2.14 | |
Gap Up/Down | -0.08 |
Fundamentals | ||
Market Capitalization (Mln) | 174 | |
EBIDTA | 13,386,000 | |
PE Ratio | 20.5682 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 12.00 | |
Book Value | 7.6670 | |
Earnings Per Share | 0.4400 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.1000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.6900 | |
Diluted EPS (TTM) | 0.4400 | |
Revenues | ||
Profit Marging | 0.0454 | |
Operating Marging (TTM) | 0.0819 | |
Return on asset (TTM) | 0.0342 | |
Return on equity (TTM) | 0.0593 | |
Revenue TTM | 158,644,000 | |
Revenue per share TTM | 9.7850 | |
Quarterly Revenue Growth (YOY) | 0.2340 | |
Quarterly Earnings Growth (YOY) | 5.8980 | |
Gross Profit (TTM) | 29,400,000 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 20.5682 | |
Forward PE | 16.1812 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 1.1827 | |
Revenue Enterprise Value | 1.0316 | |
EBITDA Enterprise Value | 10.8784 | |
Shares | ||
Shares Outstanding | 16,451,300 | |
Shares Float | 10,074,014 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 4.19 | |
Institutions (%) | 68.59 |
06/30 11:14 EST - seekingalpha.com
Ultralife Corporation Is Attractive Here
Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment.
Ultralife Corporation Is Attractive Here
Ultralife Corporation specializes in batteries for government, military, and private sectors, with a focus on communications systems. Recent growth initiatives include new product developments like EL8000 Case Systems and Thin Cell Batteries. The company has shown strong revenue growth, successful M&A track record, gross margin expansion, and stable operating expenses, making it a promising investment.
06/04 08:01 EST - investorplace.com
3 Penny Stocks Poised to Create a Boatload of New Millionaires
Penny stocks are risky yet highly lucrative if selected correctly. Moreover, penny stocks are often idiosyncratically driven, meaning they possess diversification potential.
3 Penny Stocks Poised to Create a Boatload of New Millionaires
Penny stocks are risky yet highly lucrative if selected correctly. Moreover, penny stocks are often idiosyncratically driven, meaning they possess diversification potential.
04/27 08:15 EST - seekingalpha.com
Ultralife Corporation (ULBI) Q1 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Samuel McColgan - Breakout Investors Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter Conference Call.
Ultralife Corporation (ULBI) Q1 2024 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET Company Participants Jody Burfening - IR Mike Manna - President and CEO Phil Fain - CFO Conference Call Participants Josh Sullivan - The Benchmark Company Samuel McColgan - Breakout Investors Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter Conference Call.
04/25 07:00 EST - globenewswire.com
Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights:
Ultralife Corporation Reports First Quarter Results
NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights:
04/22 11:36 EST - seekingalpha.com
Ultralife Corporation: Ready To Surge
ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024.
Ultralife Corporation: Ready To Surge
ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024.
04/11 16:01 EST - globenewswire.com
Ultralife Corporation to Report First Quarter Results on April 25, 2024
NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024.
Ultralife Corporation to Report First Quarter Results on April 25, 2024
NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024.
02/15 07:00 EST - globenewswire.com
Ultralife Corporation Reports Fourth Quarter Results
NEWARK, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2023.
Ultralife Corporation Reports Fourth Quarter Results
NEWARK, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2023.
01/29 16:30 EST - globenewswire.com
Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024
NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024.
Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024
NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024.
11/22 01:04 EST - seekingalpha.com
Ultralife: Buy The Dip
Ultralife Corporation shares have experienced a pullback of over 30%, making it an attractive investment opportunity. ULBI focuses on margin improvement and growing sales, with plans to pay down debt and evaluate further takeover targets. The company's range of new products and innovations is expected to drive revenue to new highs in FY2023 and beyond.
Ultralife: Buy The Dip
Ultralife Corporation shares have experienced a pullback of over 30%, making it an attractive investment opportunity. ULBI focuses on margin improvement and growing sales, with plans to pay down debt and evaluate further takeover targets. The company's range of new products and innovations is expected to drive revenue to new highs in FY2023 and beyond.
10/26 13:42 EST - seekingalpha.com
Ultralife Corporation (ULBI) Q3 2023 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Manna - President & Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2020 Results Conference Call.
Ultralife Corporation (ULBI) Q3 2023 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Manna - President & Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2020 Results Conference Call.
10/26 07:00 EST - globenewswire.com
Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights:
Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights:
10/12 07:00 EST - globenewswire.com
Ultralife Corporation to Report Third Quarter Results on October 26, 2023
NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023.
Ultralife Corporation to Report Third Quarter Results on October 26, 2023
NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023.
10/11 23:01 EST - seekingalpha.com
Ultralife: Stock To Outperform With Growth From Multiple Industries
Ultralife's strong revenue and earnings growth can drive the stock to above-average gains. The valuation is reasonable, leaving room for upside for the stock. Ultralife is poised to benefit over multiple years from the expected industry growth for lithium-ion batteries.
Ultralife: Stock To Outperform With Growth From Multiple Industries
Ultralife's strong revenue and earnings growth can drive the stock to above-average gains. The valuation is reasonable, leaving room for upside for the stock. Ultralife is poised to benefit over multiple years from the expected industry growth for lithium-ion batteries.
10/10 16:03 EST - seekingalpha.com
Ultralife Corporation: On The Up, But Wait For A Better Entry Point
Ultralife manufactures portable power solutions and communication systems for a range of industries. The company has put in place certain initiatives that could lead to gross margin progression this year and next. Investors are advised to wait for a pullback in the price action, considering the current risk-reward on the charts.
Ultralife Corporation: On The Up, But Wait For A Better Entry Point
Ultralife manufactures portable power solutions and communication systems for a range of industries. The company has put in place certain initiatives that could lead to gross margin progression this year and next. Investors are advised to wait for a pullback in the price action, considering the current risk-reward on the charts.
07/31 22:41 EST - seekingalpha.com
Ultralife: Backlog Increase And FCF Growth Imply Undervaluation
Ultralife Corporation reports an impressive increase in backlog, indicating potential for future net sales growth. Communications Systems segment shows significant revenue growth, driven by demand from government, defense, and medical customers. Market analysts have positive expectations for Ultralife, with projected growth in net sales, EBITDA, and net income.
Ultralife: Backlog Increase And FCF Growth Imply Undervaluation
Ultralife Corporation reports an impressive increase in backlog, indicating potential for future net sales growth. Communications Systems segment shows significant revenue growth, driven by demand from government, defense, and medical customers. Market analysts have positive expectations for Ultralife, with projected growth in net sales, EBITDA, and net income.
07/27 22:25 EST - seekingalpha.com
Ultralife Corporation (ULBI) Q2 2023 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Joshua Sullivan - The Benchmark Company Operator Good day and thank you for standing by. Welcome to the Ultralife Earnings Conference Call.
Ultralife Corporation (ULBI) Q2 2023 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Joshua Sullivan - The Benchmark Company Operator Good day and thank you for standing by. Welcome to the Ultralife Earnings Conference Call.
07/27 07:00 EST - globenewswire.com
Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., July 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights:
Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., July 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights:
07/13 07:00 EST - globenewswire.com
Ultralife Corporation to Report Second Quarter Results on July 27, 2023
NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023.
Ultralife Corporation to Report Second Quarter Results on July 27, 2023
NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023.
04/30 16:52 EST - seekingalpha.com
Ultralife Corporation (ULBI) Q1 2023 Results - Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2023 Results Conference Call.
Ultralife Corporation (ULBI) Q1 2023 Results - Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI ) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2023 Results Conference Call.
04/13 07:00 EST - globenewswire.com
Ultralife Corporation to Report First Quarter Results on April 27, 2023
NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023.
Ultralife Corporation to Report First Quarter Results on April 27, 2023
NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023.